NEW YORK (GenomeWeb News) – Geneart today released preliminary figures for its fiscal year 2008, showing a 28 percent jump in revenues to €15.7 million ($20.1 million) from €12.3 million.

The German gene synthesis firm had earnings before interest and taxes of €800,000, down from €1.8 million in 2007. It said that its profit was affected by one-time expenses associated with depreciations on inventories due to lower production costs and negative currency effects related to the US dollar.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.